Table 2 Frequency of adherence to process of care guidelines in treatment of study participants

All (n = 4931)

4931 (100%)

2411 (48.9%)

2520 (51.1%)

Lipid profile

3968 (78.9%)

1977 (80.3%)

1991 (77.4%)

Waist circumference

518 (10.3%)

279 (11.3%)

239 (9.3%)

Dietician/weight loss program referral

931 (18.5%)

449 (18.2%)

482 (18.8%)

Smoking status recorded

4805 (95.5%)

2346 (95.4%)

2459 (95.7%)

2 Blood pressure measures

3745 (74.1%)

1778 (72.2%)

1967 (76.5%)

High-Risk for CVD (n = 1143)

1143 (100%)

507 (44.4%)

636 (55.6%)

Lipid profile

904 (79.1%)

408 (80.5%)

496 (78.0%)

Waist circumference measure

85 (7.4%)

49 (9.7%)

36 (5.7%)

Dietician/weight loss program referral

142 (12.4%)

60 (11.8%)

82 (12.9%)

Smoking status recorded

1109 (97.0%)

487 (96.0%)

622 (97.8%)

2 Blood pressure measures

811 (100%)

351 (69.2%)

460 (72.3%)

Coronary Artery Disease (n = 1502)

1502 (100%)

931 (62.0%)

571 (22.4%)

Fasting blood glucose

1197 (79.7%)

749 (80.5%)

448 (78.5%)

Medication (ACE, Angiotensin receptor blocker, beta blocker)

1339 (89.2%)

830 (89.2%)

509 (89.2%)

ASA

1156 (77.0%)

725 (77.8%)

431 (75.5%)

Peripheral Vascular Disease (n = 311)

311 (100%)

191 (61.4%)

120 (38.6%)

Fasting blood glucose

244 (78.5%)

154 (80.6%)

90 (75.0%)

ACE inhibitor and/or Angiotensin receptor blocker

182 (58.5%)

110 (57.6%)

72 (60.0%)

Lipid lowering medication

232 (74.6%)

147 (76.9%)

85 (70.8%)

ASA

238 (76.5%)

147 (77.0%)

91 (75.8%)

Stroke (n = 627)

627 (100%)

293 (46.7%)

334 (53.3%)

Fasting blood glucose

474 (76.6%)

225 (77.8%)

249 (75.5%)

ASA

493 (79.6%)

231 (79.9%)

262 (79.4%)

If stroke within past year (n = 69)

69 (100%)

32 (48.4%)

37 (53.6%)

Echo cardiogram

36 (52.2%)

15 (46.9%)

21 (56.8%)

Carotid doppler

46 (66.7%)

20 (62.5%)

26 (70.3%)

CT head scan

51 (73.4%)

24 (75.0%)

27 (73.0%)

EKG

38 (55.1%)

17 (53.1%)

21 (56.8%)

Diabetes (n = 2343)

2343 (100%)

1111 (47.4%)

1232 (52.6%)

Two HbA1c tests

1275 (54.4%)

622 (56.0%)

653 (53.0%)

Glycemic control medication

1882 (80.3%)

896 (80.7%)

986 (80.0%)

ACR

1327 (56.1%)

655 (58.5%)

672 (54.0%)

eGFR

1959 (83.6%)

934 (84.1%)

1025 (83.2%)

Chronic Kidney Disease (n = 923)

923 (100%)

406 (44.0%)

517 (56.0%)

ACR

488 (52.9%)

233 (57.4%)

255 (49.3%)

Dyslipidemia ^† (n = 4207)

4207 (100%)

2124 (50.5%)

2083 (49.5%)

Lipid profile

3534 (83.2%)

1799 (83.8%)

1735 (82.6%)

Lipid lowering medication

3879 (91.4%)

1993 (92.9%)

1886 (89.8%)

Hypertension ^‡ (n = 3857)

3857 (100%)

1827 (47.4%)

2030 (52.6%)

Two blood pressure readings

3083 (79.2%)

1407 (77.1%)

1649 (81.2%)

Anti-Hypertensive medication

3627 (94.0%)

1713 (93.8%)

1914 (94.3%)

Smoking (n = 1076)

1076 (100%)

557 (51.8%)

519 (48.2%)

Smoking cessation counselling

567 (52.7%)

294 (52.8%)

273 (52.6%)

Smoking cessation program

86 (8.0%)

46 (8.3%)

40 (7.7%)

Smoking cessation drug

249 (23.0%)

128 (23.0%)

121 (23.3%)